Two research teams based at the University of Sydney have received a combined AU$7 million in funding from the New South Wales government for translational cancer research.
The grants were announced by Helen Skinner, the minister for health and medical research, on 13 January.
Administered by the Cancer Institute of NSW, the grants were awarded to the Asbestos Diseases Research Institute (ADRI) and the ANZAC Research Institute.
The ADRI team, headed by Nico van Zandwijk, will study and improve outcomes for patients with asbestos-related cancer, and the ANZAC Research Institute team, led by Derek Hart, will research the diagnosis and treatment of blood cancers.
The funding is in addition to AU$30m over a five-year period provided by the NSW government to the programme.
The broader research grants programme run by the Cancer Institute of NSW includes AU$4.3m in fellowships aimed at attracting cancer researchers to the region as well as support for researchers working in the state.